Indian Escitalopram Exporters: Complete Supplier Ranking with Market Share — 231 Manufacturers (2026) — TransData Nexus

Q: Who is the largest escitalopram supplier from India?

MEDISPRAY LABORATORIES PRIVATE LIMITED is the largest escitalopram exporter from India with a 39.4% market share and export value of $77.6M.

Q: How many escitalopram suppliers are there in India?

There are 231 active escitalopram exporters in India, collectively shipping $196.7M worth of escitalopram across 5,457 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top escitalopram suppliers from India?

The top 5 escitalopram suppliers from India — MEDISPRAY LABORATORIES PRIVATE LIMITED, AUROBINDO PHARMA LTD, TORRENT PHARMACEUTICALS LTD, SANDOZ PRIVATE LIMITED, AUROBINDO PHARMA LIMITED — together control 71.5% of total escitalopram export value from India.

Suresh Sormare

Escitalopram

India Pharmaceutical Trade Intelligence

$196.7M231 Suppliers95 CountriesHS 30049099

ExportsIndia → MOROCCO40.9%India → UNITED STATES23.6%

ImportsCANADA → India$5.3M UNITED STATES → India$18.4K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

Escitalopram Suppliers from India (2026) — 231 Exporters, $196.7M Market | TransData Nexus | TransData Nexus

Who Exports Escitalopram from India — 231 Suppliers Behind a $196.7M Market

India's escitalopram export market is supplied by 231 active exporters who collectively shipped $196.7M across 5,457 shipments. MEDISPRAY LABORATORIES PRIVATE LIMITED leads with a 39.4% market share, followed by AUROBINDO PHARMA LTD and TORRENT PHARMACEUTICALS LTD. The top 5 suppliers together control 71.5% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Escitalopram Suppliers & Exporters — 231 manufacturers, $196.7M export market, top destinations and formulations — Escitalopram supplier data — 231 exporters · $196.7M market · 5,457 shipmentsTransData Nexus · Indian Customs Data

Top Escitalopram Exporters from India — Ranked by Export Value

MEDISPRAY LABORATORIES PRIVATE LIMITED is the leading escitalopram exporter from India, holding a 39.4% share of the $196.7M market across 5,457 shipments from 231 exporters. The top 5 suppliers — MEDISPRAY LABORATORIES PRIVATE LIMITED, AUROBINDO PHARMA LTD, TORRENT PHARMACEUTICALS LTD, SANDOZ PRIVATE LIMITED, AUROBINDO PHARMA LIMITED — collectively control 71.5% of total export value, indicating a highly concentrated market. Individual shares are: MEDISPRAY LABORATORIES PRIVATE LIMITED (39.4%), AUROBINDO PHARMA LTD (11.5%), TORRENT PHARMACEUTICALS LTD (8.4%), SANDOZ PRIVATE LIMITED (6.6%), AUROBINDO PHARMA LIMITED (5.6%).

Top Escitalopram Exporters from India

Ranked by export value · 231 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Escitalopram Exporters from India — Ranked by Export Value. 231 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Escitalopram — Export Intelligence Video

Visual overview of India's escitalopram supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's escitalopram pharmaceutical supplier landscape — $196.7M in total trade, 231 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Escitalopram exporters

Certification and compliance status for top Escitalopram suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Torrent Pharmaceuticals Limited	Warning Letter, October 2	Unknown	Unknown	Not verified	FDA issued a warning letter citing CGMP violations at the Indrad facility.
Aurobindo Pharma Limited	Warning Letter, June 2019	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP deviations at the Pydibhimavaram facility.
Emcure Pharmaceuticals Limited	Warning Letter, August 20	Unknown	Unknown	Not verified	FDA issued a warning letter for CGMP violations at the Hinjawadi facility.
Intas Pharmaceuticals Limited	Approved	Yes, April 2007	Yes	Not verified	Intas received EU GMP certification in April 2007 for its biosimilar manufacturi
Sandoz Private Limited	Approved	Yes	Yes	Not verified	Sandoz facilities are approved by FDA, WHO, and EU authorities.
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Not verified	Sun Pharma's manufacturing facilities have approvals from FDA, WHO, and EU autho
Cipla Limited	Approved	Yes	Yes	Not verified	Cipla's facilities are approved by FDA, WHO, and EU authorities.
MacLeods Pharmaceuticals Ltd	Approved	Yes	Yes	Not verified	MacLeods' manufacturing facilities have approvals from FDA, WHO, and EU authorit

TransData Nexus reviewed the regulatory standing of 8 leading Escitalopram exporters from India. 5 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 5 are EU GMP compliant. 3 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Escitalopram sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts over 800 pharmaceutical companies, including prominent firms like Aurobindo Pharma Ltd., which contributed $22.5 million (11.5%) to Escitalopram exports between 2022 and 2026. The presence of Genome Valley, India's first biotech cluster, further enhances Hyderabad's capabilities in API manufacturing.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region contributes nearly 28% of India's pharmaceutical production and is home to companies like Torrent Pharmaceuticals Ltd., which accounted for $16.6 million (8.4%) of Escitalopram exports during the same period. The well-established infrastructure and regulatory compliance in this area make it a key player in the formulations sector.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for Indian pharmaceuticals. This region's proximity to major ports facilitates efficient international distribution. Companies like Sun Pharmaceutical Industries Limited, headquartered in Mumbai, contributed $10.7 million (5.5%) to Escitalopram exports between 2022 and 2026. The area's robust logistics and export infrastructure support its role as a major export hub.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Escitalopram exporters from India

November 2024

Collaboration

Aurobindo Pharma Limited — Aurobindo partners with global pharma for respiratory product development

Aurobindo Pharma USA entered into a collaboration and license agreement with an unnamed global pharmaceutical company for the development and commercialization of specific products in the respiratory therapeutic category. The agreement spans an initial development period of three to five years, with both parties sharing development costs equally, capped at $90 million for Aurobindo. - IMPACT: This collaboration is not expected to directly impact Aurobindo's Escitalopram exports, as it focuses on the respiratory segment.

Impact: This collaboration is not expected to directly impact Aurobindo's Escitalopram exports, as it focuses on the respiratory segment.

January 2025

M&A

Aurobindo Pharma Limited — Aurobindo acquires remaining stake in GLS Pharma to bolster oncology business

Aurobindo Pharma finalized the acquisition of the remaining 49% stake in GLS Pharma, a Hyderabad-based oncology company, achieving full ownership. This move enhances Aurobindo's capabilities in oncology APIs and formulations, including injectables and oral cancer therapies. - IMPACT: The acquisition is unlikely to affect Aurobindo's Escitalopram exports, as it primarily strengthens the company's oncology portfolio.

Common Questions — Escitalopram Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which escitalopram supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MEDISPRAY LABORATORIES PRIVATE LIMITED leads with 77 recorded shipments worth $77.6M. AUROBINDO PHARMA LTD (605 shipments) and TORRENT PHARMACEUTICALS LTD (242 shipments) are also established high-volume exporters.

Q How many escitalopram manufacturers are there in India?

India has 231 active escitalopram exporters with a combined export market of $196.7M across 5,457 shipments to 95 countries. The top 5 suppliers hold 71.5% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for escitalopram from India?

Average FOB unit price: $2.25 per unit, ranging from $0.00 to $805.19. Average shipment value: $36.1K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Escitalopram

Escitalopram

Who Exports Escitalopram from India — 231 Suppliers Behind a $196.7M Market

Top Escitalopram Exporters from India — Ranked by Export Value

Top Escitalopram Exporters from India

Related Analysis

Need Details?

Escitalopram — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Aurobindo Pharma Limited — Aurobindo partners with global pharma for respiratory product development

Aurobindo Pharma Limited — Aurobindo acquires remaining stake in GLS Pharma to bolster oncology business

Common Questions — Escitalopram Suppliers from India

Q Which escitalopram supplier from India is the most reliable for bulk orders?

Q How many escitalopram manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for escitalopram from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Torrent Pharmaceuticals Limited — Torrent Pharma acquires controlling stake in J.B. Chemicals from KKR

Analysis Methodology